Related Experiment Videos
[3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and
M A Piggott1, E K Perry, R H Perry
1MRC Neurochemical Pathology Unit, Newcastle General Hospital, Newcastle upon Tyne, UK.
Brain Research
|August 21, 1992
Summary
[3H]MK-801 binding sites in the human frontal cortex decline significantly with age. This age-related loss, not altered affinity, impacts NMDA receptor function and has developmental implications.
Area of Science:
- Neuroscience
- Neurochemistry
- Aging Research
Background:
- The N-methyl-D-aspartate (NMDA) receptor is crucial for synaptic plasticity and cognitive function.
- Age-related changes in NMDA receptor function may contribute to neurodegenerative processes.
- MK-801 is a non-competitive antagonist that binds to the ion channel of the NMDA receptor.
Purpose of the Study:
- To investigate age-related changes in [3H]MK-801 binding in the human frontal cortex.
- To determine the effect of modulators (glutamate, glycine, spermidine, zinc) on age-related binding.
- To explore developmental differences in modulator effects.
Main Methods:
- Human frontal cortex tissue from 24 weeks gestation to 100 years old was used.
- [3H]MK-801 binding assays were performed under basal and stimulated conditions.
- Scatchard analysis was employed to assess binding affinity and site number.
Main Results:
- A significant age-related decline in [3H]MK-801 binding was observed, primarily due to a loss of binding sites.
- Glutamate, glycine, and spermidine significantly enhanced binding in adults, while zinc attenuated it.
- Spermidine showed an inhibitory effect in fetal and neonatal cases, contrasting with its stimulatory role in adults.
Conclusions:
- NMDA receptor function, indicated by [3H]MK-801 binding, decreases with age in the human frontal cortex.
- Developmental differences in polyamine (spermidine) modulation of NMDA receptors exist.
- These findings suggest potential therapeutic strategies for neonatal conditions involving NMDA receptor pathways.